Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study.

Fouad A, Sabry D, Ahmed R, Kamal M, Allah SA, Marzouk S, Amin M, Abd El Aziz R, El Badri A, Khattab H, Helmy D.

Int J Gen Med. 2013 Mar 12;6:127-34. doi: 10.2147/IJGM.S36433. Print 2013.

2.

Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.

Am J Gastroenterol. 2003 May;98(5):1150-4.

PMID:
12809841
3.

Lipid profile and hepatic steatosis in hepatitis C infected egyptian survivors of childhood cancer.

Al-Tawil MM, Shoeeb AS, Abbas A, El-Tawil A, El-Sayed MH.

Pediatr Hematol Oncol. 2015 Feb;32(1):70-7. doi: 10.3109/08880018.2013.825355. Epub 2013 Sep 19.

PMID:
24050726
4.
5.

Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.

Kara B, Gunesacar R, Doran F, Kara IO, Akkiz H.

Adv Ther. 2007 Sep-Oct;24(5):972-82.

PMID:
18029322
6.

Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia.

Dolmazashvili E, Zhamutashvili M, Svanidze M, Nizharadze N, Abutidze A.

Georgian Med News. 2008 Dec;(165):83-7.

PMID:
19124923
7.

Factors associated with steatosis in liver biopsies of individuals with chronic hepatitis C infection in southern Brazil.

Giustina RD, Marconcini ML, Bansho ET, Tonon D, Pasinato AP, Dantas-Corrêa EB, Schiavon LL, Narciso-Schiavon JL.

Arab J Gastroenterol. 2015 Jun;16(2):59-62. doi: 10.1016/j.ajg.2015.06.002. Epub 2015 Jul 10.

PMID:
26169501
8.

Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.

Mirandola S, Realdon S, Iqbal J, Gerotto M, Dal Pero F, Bortoletto G, Marcolongo M, Vario A, Datz C, Hussain MM, Alberti A.

Gastroenterology. 2006 May;130(6):1661-9. Epub 2006 Mar 6.

PMID:
16697730
9.

Mechanisms and significance of liver steatosis in hepatitis C virus infection.

Negro F.

World J Gastroenterol. 2006 Nov 14;12(42):6756-65. Review.

10.

Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.

Ramcharran D, Wahed AS, Conjeevaram HS, Evans RW, Wang T, Belle SH, Yee LJ.

J Viral Hepat. 2011 Apr;18(4):e144-52. doi: 10.1111/j.1365-2893.2010.01394.x. Epub 2010 Nov 10.

11.

Hepatic steatosis in Iranian patients with chronic hepatitis C.

Minakari M, Sameni FK, Shalmani HM, Molaee M, Zali MR.

Med Princ Pract. 2008;17(2):126-30. doi: 10.1159/000112966. Epub 2008 Feb 19.

12.

Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.

Fouad SA, Esmat S, Omran D, Rashid L, Kobaisi MH.

World J Gastroenterol. 2012 Jun 21;18(23):2988-94. doi: 10.3748/wjg.v18.i23.2988.

13.

Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus.

Woreta TA, Sutcliffe CG, Mehta SH, Brown TT, Higgins Y, Thomas DL, Torbenson MS, Moore RD, Sulkowski MS.

Gastroenterology. 2011 Mar;140(3):809-17. doi: 10.1053/j.gastro.2010.11.052. Epub 2010 Dec 4.

14.

Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.

Tachi Y, Katano Y, Honda T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Samejima Y, Goto H.

Liver Int. 2010 Apr;30(4):554-9. doi: 10.1111/j.1478-3231.2009.02164.x. Epub 2009 Nov 27.

PMID:
19951380
15.

Hepatitis C virus infection and liver steatosis.

Ramalho F.

Antiviral Res. 2003 Oct;60(2):125-7. Review.

PMID:
14638408
16.

Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.

Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Robuck PR, Schwarz KB.

Hepatology. 2008 Mar;47(3):836-43. doi: 10.1002/hep.22094.

17.

Steatosis and intrahepatic hepatitis C virus in chronic hepatitis.

Fujie H, Yotsuyanagi H, Moriya K, Shintani Y, Tsutsumi T, Takayama T, Makuuchi M, Matsuura Y, Miyamura T, Kimura S, Koike K.

J Med Virol. 1999 Oct;59(2):141-5.

PMID:
10459147
18.

Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.

Liu CJ, Jeng YM, Chen PJ, Lai MY, Yang HC, Huang WL, Kao JH, Chen DS.

Antivir Ther. 2005;10(3):405-15.

PMID:
15918331
19.

Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.

Giannini E, Ceppa P, Botta F, Mastracci L, Romagnoli P, Comino I, Pasini A, Risso D, Lantieri PB, Icardi G, Barreca T, Testa R.

Am J Gastroenterol. 2000 Nov;95(11):3211-7.

PMID:
11095344
20.

Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection.

Ahmed AM, Hassan MS, Abd-Elsayed A, Hassan H, Hasanain AF, Helmy A.

Saudi J Gastroenterol. 2011 Jul-Aug;17(4):245-51. doi: 10.4103/1319-3767.82578.

Supplemental Content

Support Center